HIV News Alert
Updates to the Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States
January 31, 2023: The Panel on Treatment of HIV in Pregnancy and Prevention of Perinatal Transmission (the Panel) updated the Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. The clinical guidelines for infant feeding now support shared decision making and clarify breastfeeding options for people with…
Read MoreUpdates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
September 28, 2022: The Panel on Opportunistic Infections in Adults and Adolescents (the Panel) updated the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Highlights from the updated section are summarized below: Monkeypox: Added links to useful government and professional association websites.For a list of recent updates, please…
Read MoreUpdates to the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
October 11, 2022: The Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV (the Panel) has made revisions in the following sections of the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection to address U.S. Food and Drug Administration approval of the dispersible tablet formulation of the fixed-dose combination…
Read MoreCDC releases Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection
CDC has released Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection. On August 4, 2022, the United States declared monkeypox a public health emergency. The current outbreak disproportionately affects gay, bisexual, and other men who have sex with men (MSM). MSM are also disproportionately affected by HIV. A recent study provides insights into…
Read MoreUpdates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
The Panel on Opportunistic Infections in Adults and Adolescents (the Panel) updated the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Highlights from the updated section are summarized below: Monkeypox Added a brief statement about monkeypox with a link to information from the Centers for Disease Control and Prevention (CDC). Information…
Read MoreIllinois Governor Pritzker Issues Monkeypox Virus Public Health Emergency Declaration to Coordinate Statewide Response
Monday, August 01, 2022: CHICAGO—Governor Pritzker issued a proclamation today declaring the monkeypox virus a public health emergency and declaring the state of Illinois a disaster area regarding the disease. The declaration, which applies to the entire state, will allow the Illinois Department of Public Health (IDPH) to utilize resources for coordinating logistics across state…
Read MoreCDC releases letter for health care professionals on addressing pain control in persons with monkeypox.
As the 2022 monkeypox outbreak continues to accelerate, the Centers for Disease Control and Prevention recently released a “Dear Colleague Letter” for health care providers and care team members highlighting the importance of addressing pain control in persons with monkeypox. To view the letter (PDF) click here or view below.
Read MoreIllinois Governor Signs Bills Expanding Access to HIV and AIDS-Related Care and Prevention
June 10, 2022: Governor JB Pritzker of Illinois signed HB4430 and HB5549 into law today, removing barriers to access for HIV and AIDS care and prevention. HB4430 allows pharmacists to dispense both pre- and post-exposure prophylaxis drugs (PrEP and PEP) without a prior referral from a doctor. HB5549 ensures funding from the African American HIV/AIDS…
Read MoreNew National Drug Control Strategy Release: HIV-related Impact
The 2022 National Drug Control Strategy was released on April 21, 2022. Over the course of a year, it was developed through requests for written consultations from more than 2,000 external stakeholders, including the entirety of the U.S. Congress; all 50 Governors; and hundreds of advocates representing law enforcement, public health, and Tribal communities. This new Strategy…
Read MoreUpdated HHS Pediatric Antiretroviral Therapy Guidelines Released
April 12, 2022: The Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV (the Panel) has reviewed the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Key updates are summarized below: The U.S. Food and Drug Administration (FDA) recently approved long-acting injectable cabotegravir and rilpivirine (Cabenuva) for use in children and…
Read More